Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Merck To Revisit M&A Strategy Under CEO Clark; Is A Merger In The Mix?

Executive Summary

Merck will revisit its merger and acquisition strategy under newly appointed CEO Richard Clark, with all options - including a large-scale merger - on the table

You may also be interested in...



Merck Taps Clark As CEO In Nod To Medco Heritage; Gilmartin To Retire

Merck's appointment of Richard Clark to succeed retiring CEO Ray Gilmartin continues the Medco legacy at Merck's senior management level

Merck Taps Clark As CEO In Nod To Medco Heritage; Gilmartin To Retire

Merck's appointment of Richard Clark to succeed retiring CEO Ray Gilmartin continues the Medco legacy at Merck's senior management level

Merck Drops Strict “No Merger” Policy, But Still Prefers Licensing Deals

Merck appears to be distancing itself from a blanket "no merger" policy by offering a formula under which it would consider a large-scale transaction

Topics

UsernamePublicRestriction

Register

ID1132327

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel